The US Food and Drug Administration (FDA) takes steps to protect against threats to the pharmaceutical supply chain posed by extreme weather events.
Counterfeit drugs adversely impact both consumers and pharmaceutical companies. Can blockchain help solve this problem?
With its destructive power, Hurricane Maria revealed the fragility of the global pharmaceutical supply chain when it struck Puerto Rico, a major drug manufacturing hub, earlier this year. How can US regulatory bodies mitigate the impact climate change, and the resulting “super storms”, has on drug availability?
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?